Personalized Oncology – Fulfilling the Promise for Today’s Patients
In honor of the 20th anniversary of the Molecular Medicine Tri-Conference, CHI and Cancer Commons presented a plenary panel on Personalized Oncology. Innovations such as NGS and The Cancer Genome Atlas have revealed that cancer comprises hundreds of distinct molecular diseases. Early clinical successes with targeted therapies suggest that cancer might one day be managed as a chronic disease using an evolving cocktail of drugs. Representing all five conference channels, Diagnostics, Therapeutics, Clinical, Informatics, and Cancer, a panel of experts led a highly interactive exploration of what it will take to realize this vision in the near future.
For more details, see the Cancer Commons website.
To view the presentation, see TriCon 2 13 13 Deck